Cargando…
Evaluation of perfluorooctanoate for potential genotoxicity
Perfluorooctanoate (PFOA) is a fully fluorinated eight-carbon fatty acid analog with exceptional stability toward degradation that has been used as an industrial surfactant and has been detected in environmental and biological matrices. Exposures to PFOA in the workplace and in the environment have...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598378/ https://www.ncbi.nlm.nih.gov/pubmed/28962243 http://dx.doi.org/10.1016/j.toxrep.2014.05.012 |
_version_ | 1783263893165965312 |
---|---|
author | Butenhoff, John L. Kennedy, Gerald L. Jung, Reinhard Chang, Shu-Ching |
author_facet | Butenhoff, John L. Kennedy, Gerald L. Jung, Reinhard Chang, Shu-Ching |
author_sort | Butenhoff, John L. |
collection | PubMed |
description | Perfluorooctanoate (PFOA) is a fully fluorinated eight-carbon fatty acid analog with exceptional stability toward degradation that has been used as an industrial surfactant and has been detected in environmental and biological matrices. Exposures to PFOA in the workplace and in the environment have continuously stimulated investigations into its potential human health hazards. In this article, the results of fifteen unpublished genotoxicity assays conducted with perfluorooctanoate (as either the linear or linear/branched ammonium salt (APFO) or the linear/branched sodium salt) are reported and include: seven mutation assays (three in vitro reverse mutation assays with histidine auxotrophic strains of Salmonella typhimurium, two in vitro reverse mutation assays with the tryptophan auxotrophic Escherichia coli WP2uvr strain, one in vitro mitotic recombination (gene conversion) assay with Saccharomyces cerevisiae D4, and an in vitro Chinese hamster ovary (CHO) HGPRT forward mutation assay); seven studies to assess potential for chromosomal damage (three in vitro CHO chromosomal aberration studies, an in vitro human whole blood lymphocyte chromosomal aberration study, and three in vivo mouse micronucleus assays); and an in vitro C3H 10T1/2 cell transformation assay. Although PFOA has not been demonstrated to be metabolized, all in vitro assays were conducted both in the presence and in the absence of a mammalian hepatic microsomal activation system. These assays were originally described in twelve contract laboratory reports which have been available via the United States Environmental Protection Agency public docket (Administrative Record 226) for over a decade; however, the details of these assays have not been published previously in the open scientific literature. With the exception of limited positive findings at high and cytotoxic concentrations in some assay trials which reflected the likely consequence of cytotoxic disruption of normal cellular processes and not a specific genotoxic effect, the results of the studies presented in this paper and other published results clearly demonstrate the absence of direct mutagenic or genotoxic risk associated with PFOA. This finding is consistent with the physical/chemical characteristics of PFOA and is supported by other published genotoxicity studies. |
format | Online Article Text |
id | pubmed-5598378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-55983782017-09-28 Evaluation of perfluorooctanoate for potential genotoxicity Butenhoff, John L. Kennedy, Gerald L. Jung, Reinhard Chang, Shu-Ching Toxicol Rep Article Perfluorooctanoate (PFOA) is a fully fluorinated eight-carbon fatty acid analog with exceptional stability toward degradation that has been used as an industrial surfactant and has been detected in environmental and biological matrices. Exposures to PFOA in the workplace and in the environment have continuously stimulated investigations into its potential human health hazards. In this article, the results of fifteen unpublished genotoxicity assays conducted with perfluorooctanoate (as either the linear or linear/branched ammonium salt (APFO) or the linear/branched sodium salt) are reported and include: seven mutation assays (three in vitro reverse mutation assays with histidine auxotrophic strains of Salmonella typhimurium, two in vitro reverse mutation assays with the tryptophan auxotrophic Escherichia coli WP2uvr strain, one in vitro mitotic recombination (gene conversion) assay with Saccharomyces cerevisiae D4, and an in vitro Chinese hamster ovary (CHO) HGPRT forward mutation assay); seven studies to assess potential for chromosomal damage (three in vitro CHO chromosomal aberration studies, an in vitro human whole blood lymphocyte chromosomal aberration study, and three in vivo mouse micronucleus assays); and an in vitro C3H 10T1/2 cell transformation assay. Although PFOA has not been demonstrated to be metabolized, all in vitro assays were conducted both in the presence and in the absence of a mammalian hepatic microsomal activation system. These assays were originally described in twelve contract laboratory reports which have been available via the United States Environmental Protection Agency public docket (Administrative Record 226) for over a decade; however, the details of these assays have not been published previously in the open scientific literature. With the exception of limited positive findings at high and cytotoxic concentrations in some assay trials which reflected the likely consequence of cytotoxic disruption of normal cellular processes and not a specific genotoxic effect, the results of the studies presented in this paper and other published results clearly demonstrate the absence of direct mutagenic or genotoxic risk associated with PFOA. This finding is consistent with the physical/chemical characteristics of PFOA and is supported by other published genotoxicity studies. Elsevier 2014-05-27 /pmc/articles/PMC5598378/ /pubmed/28962243 http://dx.doi.org/10.1016/j.toxrep.2014.05.012 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Article Butenhoff, John L. Kennedy, Gerald L. Jung, Reinhard Chang, Shu-Ching Evaluation of perfluorooctanoate for potential genotoxicity |
title | Evaluation of perfluorooctanoate for potential genotoxicity |
title_full | Evaluation of perfluorooctanoate for potential genotoxicity |
title_fullStr | Evaluation of perfluorooctanoate for potential genotoxicity |
title_full_unstemmed | Evaluation of perfluorooctanoate for potential genotoxicity |
title_short | Evaluation of perfluorooctanoate for potential genotoxicity |
title_sort | evaluation of perfluorooctanoate for potential genotoxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598378/ https://www.ncbi.nlm.nih.gov/pubmed/28962243 http://dx.doi.org/10.1016/j.toxrep.2014.05.012 |
work_keys_str_mv | AT butenhoffjohnl evaluationofperfluorooctanoateforpotentialgenotoxicity AT kennedygeraldl evaluationofperfluorooctanoateforpotentialgenotoxicity AT jungreinhard evaluationofperfluorooctanoateforpotentialgenotoxicity AT changshuching evaluationofperfluorooctanoateforpotentialgenotoxicity |